Further, it is interesting to note that MAO-A inhibitors, medications that have been successfully used to treat several kinds of neurological disorders by inhibiting MAO-A's activity in the brain and preventing the breakdown of monoamine neurotransmitters, can also inhibit MAO-A activity in TAMs of human breast cancers and melanomas. Here, MAOA is linked to breast carcinoma.